{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:25:14Z","timestamp":1793157914030,"version":"4.5.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.arcmed.2023.102899","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T18:15:11Z","timestamp":1698948911000},"page":"102899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Clinical Spectrum of USP8 Pathogenic Variants in Cushing's Disease"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9293-5959","authenticated-orcid":false,"given":"Rosa G.","family":"Rebollar-Vega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7872-7160","authenticated-orcid":false,"given":"Julia M.","family":"Zuarth-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6599-6406","authenticated-orcid":false,"given":"Laura C.","family":"Hern\u00e1ndez-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2023.102899_bib0001","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2265.1994.tb02486.x","article-title":"Morbidity and mortality in Cushing's disease: an epidemiological approach","volume":"404","author":"Etxabe","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.arcmed.2023.102899_bib0002","first-page":"117","article-title":"Incidence and late prognosis of Cushing's syndrome: a population-based study","volume":"861","author":"Lindholm","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102899_bib0003","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11102-019-00951-1","article-title":"The incidence of Cushing's disease: a nationwide Swedish study","volume":"222","author":"Ragnarsson","year":"2019","journal-title":"Pituitary"},{"key":"10.1016\/j.arcmed.2023.102899_bib0004","first-page":"137","article-title":"The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism)","volume":"50","author":"Cushing","year":"1932","journal-title":"Bull Johns Hopkins Hosp"},{"key":"10.1016\/j.arcmed.2023.102899_bib0005","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","article-title":"Cushing's syndrome","volume":"3679522","author":"Newell-Price","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2023.102899_bib0006","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1210\/jc.2005-0070","article-title":"Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas","volume":"908","author":"Woo","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102899_bib0007","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3171\/JNS\/2008\/108\/01\/0009","article-title":"Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years","volume":"1081","author":"Hofmann","year":"2008","journal-title":"J Neurosurg"},{"key":"10.1016\/j.arcmed.2023.102899_bib0008","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1530\/EJE-11-0272","article-title":"The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics","volume":"1653","author":"Valassi","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102899_bib0009","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing's syndrome","volume":"3869996","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2023.102899_bib0010","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/pr.2017.58","article-title":"Pediatric Cushing disease: disparities in disease severity and outcomes in the Hispanic and African-American populations","volume":"822","author":"Gkourogianni","year":"2017","journal-title":"Pediatr Res"},{"key":"10.1016\/j.arcmed.2023.102899_bib0011","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline","volume":"935","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102899_bib0012","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","volume":"912","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102899_bib0013","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1210\/clinem\/dgz136","article-title":"Time to diagnosis in Cushing's syndrome: A meta-analysis based on 5367 patients","volume":"1053","author":"Rubinstein","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102899_bib0014","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing's syndrome: state of the art","volume":"47","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102899_bib0015","article-title":"Epidemiology and mortality of Cushing's syndrome","volume":"351","author":"Hakami","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102899_bib0016","doi-asserted-by":"crossref","first-page":"e1316","DOI":"10.1210\/clinem\/dgaa858","article-title":"The hypothalamic-pituitary-thyroid axis in Cushing syndrome before and after curative surgery","volume":"1063","author":"Shekhar","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102899_bib0017","doi-asserted-by":"crossref","first-page":"R207","DOI":"10.1530\/EJE-20-1309","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: Cardiovascular risk assessment, thromboembolism, and infection prevention in Cushing's syndrome: a practical approach","volume":"1845","author":"Varlamov","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102899_bib0018","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1210\/jc.2003-030871","article-title":"Diagnosis and complications of Cushing's syndrome: a consensus statement","volume":"8812","author":"Arnaldi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102899_bib0019","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1530\/EJE-10-0962","article-title":"Assessment of ACTH assay variability: a multicenter study","volume":"1644","author":"Pecori Giraldi","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102899_bib0020","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1210\/clinem\/dgac686","article-title":"Dynamic testing for differential diagnosis of ACTH-dependent Cushing syndrome: A systematic review and meta-analysis","volume":"1085","author":"Ceccato","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102899_bib0021","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12902-022-01069-5","article-title":"MRI-negative Cushing's disease: Management strategy and outcomes in 15 cases utilizing a pure endoscopic endonasal approach","volume":"221","author":"Sharifi","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.arcmed.2023.102899_bib0022","first-page":"244","article-title":"Determinants of clinical behavior and prognosis in Cushing's disease: A quest for useful biomarkers","volume":"745","author":"Hern\u00e1ndez-Ram\u00edrez","year":"2022","journal-title":"Rev Invest Clin"},{"key":"10.1016\/j.arcmed.2023.102899_bib0023","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2265.2005.02380.x","article-title":"Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance","volume":"635","author":"Atkinson","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.arcmed.2023.102899_bib0024","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1210\/jc.2007-2013","article-title":"Late recurrences of Cushing's disease after initial successful transsphenoidal surgery","volume":"932","author":"Patil","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102899_bib0025","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1210\/jc.2017-01385","article-title":"Stereotactic radiosurgery for Cushing disease: Results of an international, multicenter study","volume":"10211","author":"Mehta","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102899_bib0026","article-title":"Therapeutic options after surgical failure in Cushing's disease: A critical review","volume":"332","author":"Rubinstein","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102899_bib0027","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1210\/jc.2007-2734","article-title":"Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement","volume":"937","author":"Biller","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102899_bib0028","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of Cushing's syndrome: An Endocrine Society clinical practice guideline","volume":"1008","author":"Nieman","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102899_bib0029","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1210\/er.2013-1048","article-title":"The treatment of Cushing's disease","volume":"364","author":"Pivonello","year":"2015","journal-title":"Endocr Rev"},{"key":"10.1016\/j.arcmed.2023.102899_bib0030","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S2213-8587(18)30155-4","article-title":"Advances in the medical treatment of Cushing's syndrome","volume":"74","author":"Feelders","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102899_bib0031","doi-asserted-by":"crossref","first-page":"e2455","DOI":"10.1210\/clinem\/dgaa969","article-title":"Genomics in Cushing's disease: The dawn of a new era","volume":"1066","author":"Reincke","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102899_bib0032","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/17446651.2017.1306439","article-title":"Sporadic pituitary adenomas: the role of germline mutations and recommendations for genetic screening","volume":"122","author":"Iacovazzo","year":"2017","journal-title":"Expert Rev Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102899_bib0033","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1016\/j.gim.2022.08.021","article-title":"Genetic drivers of Cushing's disease: Frequency and associated phenotypes","volume":"2412","author":"Hern\u00e1ndez-Ram\u00edrez","year":"2022","journal-title":"Genet Med"},{"key":"10.1016\/j.arcmed.2023.102899_bib0034","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s40478-022-01437-1","article-title":"TP53 mutations in functional corticotroph tumors are linked to invasion and worse clinical outcome","volume":"101","author":"P\u00e9rez-Rivas","year":"2022","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.arcmed.2023.102899_bib0035","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/cr.2015.20","article-title":"Recurrent gain-of-function USP8 mutations in Cushing's disease","volume":"253","author":"Ma","year":"2015","journal-title":"Cell Res"},{"key":"10.1016\/j.arcmed.2023.102899_bib0036","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ng.3166","article-title":"Mutations in the deubiquitinase gene USP8 cause Cushing's disease","volume":"471","author":"Reincke","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.arcmed.2023.102899_bib0037","doi-asserted-by":"crossref","first-page":"E997","DOI":"10.1210\/jc.2015-1453","article-title":"The gene of the ubiquitin-specific protease 8 is frequently mutated in adenomas causing Cushing's disease","volume":"1007","author":"P\u00e9rez-Rivas","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102899_bib0038","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/neuonc\/noz109","article-title":"Driver mutations in USP8 wild-type Cushing's disease","volume":"2110","author":"Sbiera","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.arcmed.2023.102899_bib0039","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1530\/EJE-15-0689","article-title":"The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease","volume":"1742","author":"Hayashi","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102899_bib0040","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1210\/jc.2017-00161","article-title":"Somatic USP8 gene mutations are a common cause of pediatric Cushing disease","volume":"1028","author":"Faucz","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102899_bib0041","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.1210\/jc.2019-00697","article-title":"Germline USP8 mutation associated with pediatric Cushing disease and other clinical features: A new syndrome","volume":"10410","author":"Cohen","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102899_bib0042","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5603\/EP.a2020.0073","article-title":"Is there a common cause for paediatric Cushing's disease?","volume":"722","author":"Pasternak-Pietrzak","year":"2021","journal-title":"Endokrynol Pol"},{"key":"10.1016\/j.arcmed.2023.102899_bib0043","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fendo.2017.00055","article-title":"Transcriptome analysis showed a differential signature between invasive and non-invasive corticotrophinomas","volume":"8","author":"de Ara\u00fajo","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.arcmed.2023.102899_bib0044","doi-asserted-by":"crossref","DOI":"10.1111\/cen.13802","article-title":"The USP8 mutational status may predict long-term remission in patients with Cushing's disease","author":"Albani","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.arcmed.2023.102899_bib0045","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1210\/js.2017-00364","article-title":"USP8 mutations in pituitary Cushing adenomas-targeted analysis by next-generation sequencing","volume":"23","author":"Ballmann","year":"2018","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.arcmed.2023.102899_bib0046","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1530\/EJE-19-0194","article-title":"USP8 mutations in corticotroph adenomas determine a distinct gene expression profile irrespective of functional tumour status","volume":"1816","author":"Bujko","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102899_bib0047","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12020-018-1776-0","article-title":"Clinical characteristics and surgical outcome in USP8-mutated human adrenocorticotropic hormone-secreting pituitary adenomas","volume":"632","author":"Losa","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.arcmed.2023.102899_bib0048","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1210\/jc.2018-02564","article-title":"Impact of USP8 gene mutations on protein deregulation in Cushing disease","volume":"1047","author":"Weigand","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102899_bib0049","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1530\/EC-20-0035","article-title":"SST5 expression and USP8 mutation in functioning and silent corticotroph pituitary tumors","volume":"93","author":"Castellnou","year":"2020","journal-title":"Endocr Connect"},{"key":"10.1016\/j.arcmed.2023.102899_bib0050","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000500688","article-title":"Ubiquitin-specific protease 8 mutant corticotrope adenomas present unique secretory and molecular features and shed light on the role of ubiquitylation on ACTH processing","volume":"1101\u20132","author":"Sesta","year":"2020","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.arcmed.2023.102899_bib0051","first-page":"1316","article-title":"Genetic profiling of a cohort of Italian patients with ACTH-secreting pituitary tumors and characterization of a novel USP8 gene variant","author":"Treppiedi","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.arcmed.2023.102899_bib0052","first-page":"117","article-title":"USP8 mutations and cell cycle regulation in corticotroph adenomas","volume":"522","author":"Martins","year":"2020","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.arcmed.2023.102899_bib0053","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s12020-021-02903-x","article-title":"USP8, USP48, and BRAF mutations differ in their genotype-phenotype correlation in Asian Indian patients with Cushing's disease","volume":"752","author":"Abraham","year":"2022","journal-title":"Endocrine"},{"key":"10.1016\/j.arcmed.2023.102899_bib0054","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s11102-022-01220-4","article-title":"Responsiveness to DDAVP in Cushing's disease is associated with USP8 mutations through enhancing AVPR1B promoter activity","volume":"253","author":"Shichi","year":"2022","journal-title":"Pituitary"},{"key":"10.1016\/j.arcmed.2023.102899_bib0055","first-page":"59","article-title":"Somatic USP8 mutations are frequent events in corticotroph tumor progression causing Nelson's tumor","volume":"1781","author":"P\u00e9rez-Rivas","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102899_bib0056","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1210\/clinem\/dgaa853","article-title":"USP8 and TP53 drivers are associated with CNV in a corticotroph adenoma cohort enriched for aggressive tumors","volume":"1063","author":"Uzilov","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102899_bib0057","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.3390\/ijms23094861","article-title":"The genomic landscape of corticotroph tumors: From silent adenomas to ACTH-secreting carcinomas","volume":"239","author":"Andonegui-Elguera","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.arcmed.2023.102899_bib0058","doi-asserted-by":"crossref","first-page":"e12628","DOI":"10.1111\/jne.12628","article-title":"Gene expression profiling in human corticotroph tumours reveals distinct, neuroendocrine profiles","volume":"309","author":"Cassarino","year":"2018","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.arcmed.2023.102899_bib0059","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ccell.2019.11.002","article-title":"Pangenomic classification of pituitary neuroendocrine tumors","volume":"371","author":"Neou","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.arcmed.2023.102899_bib0060","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1530\/ERC-22-0088","article-title":"Improved pasireotide response in USP8 mutant corticotroph tumours in vitro","volume":"298","author":"Albani","year":"2022","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.arcmed.2023.102899_bib0061","doi-asserted-by":"crossref","first-page":"8275","DOI":"10.1074\/jbc.RA117.001315","article-title":"The ubiquitin-specific protease USP8 deubiquitinates and stabilizes Cx43","volume":"29321","author":"Sun","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2023.102899_bib0062","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/s42003-021-02802-x","article-title":"Molecular basis of ubiquitin-specific protease 8 autoinhibition by the WW-like domain","volume":"41","author":"Kakihara","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.arcmed.2023.102899_bib0063","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.cell.2010.11.012","article-title":"Ubiquitin: same molecule, different degradation pathways","volume":"1435","author":"Clague","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.arcmed.2023.102899_bib0064","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1091\/mbc.e05-06-0560","article-title":"Regulation of epidermal growth factor receptor down-regulation by UBPY-mediated deubiquitination at endosomes","volume":"1611","author":"Mizuno","year":"2005","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.arcmed.2023.102899_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2021.108811","article-title":"The oncogenic role of ubiquitin specific peptidase (USP8) and its signaling pathways targeting for cancer therapeutics","volume":"701","author":"Islam","year":"2021","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.arcmed.2023.102899_bib0066","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1074\/jbc.M604711200","article-title":"UBPY-mediated epidermal growth factor receptor (EGFR) de-ubiquitination promotes EGFR degradation","volume":"2823","author":"Alwan","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2023.102899_bib0067","doi-asserted-by":"crossref","first-page":"34909","DOI":"10.1074\/jbc.M109.016287","article-title":"Regulation of epidermal growth factor receptor ubiquitination and trafficking by the USP8.STAM complex","volume":"28545","author":"Berlin","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2023.102899_bib0068","article-title":"CHMP1B is a target of USP8\/UBPY regulated by ubiquitin during endocytosis","volume":"146","author":"Crespo-Y\u00e0\u00f1ez","year":"2018","journal-title":"PLoS Genet"},{"key":"10.1016\/j.arcmed.2023.102899_bib0069","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41580-019-0099-1","article-title":"Breaking the chains: deubiquitylating enzyme specificity begets function","volume":"206","author":"Clague","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.arcmed.2023.102899_bib0070","doi-asserted-by":"crossref","first-page":"10051","DOI":"10.1002\/jcb.27337","article-title":"The expression of ubiquitin-specific peptidase 8 and its prognostic role in patients with breast cancer","volume":"11912","author":"Qiu","year":"2018","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.arcmed.2023.102899_bib0071","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41418-019-0419-1","article-title":"Deubiquitylation and stabilization of Notch1 intracellular domain by ubiquitin-specific protease 8 enhance tumorigenesis in breast cancer","volume":"274","author":"Shin","year":"2020","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.arcmed.2023.102899_bib0072","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.12659\/MSM.909235","article-title":"High expression of ubiquitin-specific protease 8 (USP8) Is associated with poor prognosis in patients with cervical squamous cell carcinoma","volume":"24","author":"Yan","year":"2018","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.arcmed.2023.102899_bib0073","doi-asserted-by":"crossref","first-page":"7973","DOI":"10.2147\/OTT.S264108","article-title":"Down-regulation of USP8 suppresses HER-3 positive gastric cancer cells proliferation","volume":"13","author":"Sun","year":"2020","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.arcmed.2023.102899_bib0074","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.923270","article-title":"Knockdown of USP8 inhibits prostate cancer cell growth, proliferation, and metastasis and promotes docetaxel's activity by suppressing the NF-kB signaling pathway","volume":"12","author":"Islam","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.arcmed.2023.102899_bib0075","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/j.febslet.2009.06.018","article-title":"Dexamethasone regulates expression of BRUCE\/Apollon and the proliferation of neural progenitor cells","volume":"58313","author":"Sippel","year":"2009","journal-title":"FEBS Lett"},{"key":"10.1016\/j.arcmed.2023.102899_bib0076","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/EJE-15-1064","article-title":"Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas","volume":"1743","author":"Ronchi","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102899_bib0077","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1158\/1078-0432.CCR-16-0790","article-title":"Landscape of genomic alterations in pituitary adenomas","volume":"237","author":"Bi","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.arcmed.2023.102899_bib0078","doi-asserted-by":"crossref","first-page":"L73","DOI":"10.1530\/ERC-17-0054","article-title":"Expression and mutational status of USP8 in tumors causing ectopic ACTH secretion syndrome","volume":"249","author":"P\u00e9rez-Rivas","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.arcmed.2023.102899_bib0079","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.731579","article-title":"Case Report: Consecutive adrenal Cushing's syndrome and Cushing's disease in a patient with somatic CTNNB1, USP8, and NR3C1 mutations","volume":"12","author":"Detomas","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.arcmed.2023.102899_bib0080","article-title":"Identification of a novel RASD1 somatic mutation in a USP8-mutated corticotroph adenoma","volume":"33","author":"Uzilov","year":"2017","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"10.1016\/j.arcmed.2023.102899_bib0081","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/cr.2016.114","article-title":"The genome-wide mutational landscape of pituitary adenomas","volume":"2611","author":"Song","year":"2016","journal-title":"Cell Res"},{"key":"10.1016\/j.arcmed.2023.102899_bib0082","first-page":"1410","article-title":"P720R USP8 mutation is associated with a better responsiveness to pasireotide in ACTH-secreting PitNETs","author":"Treppiedi","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.arcmed.2023.102899_bib0083","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.2147\/CMAR.S234586","article-title":"Down-regulation of USP8 inhibits cholangiocarcinoma cell proliferation and invasion","volume":"12","author":"Jing","year":"2020","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.arcmed.2023.102899_bib0084","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1158\/1078-0432.CCR-12-3696","article-title":"USP8 is a novel target for overcoming gefitinib resistance in lung cancer","volume":"1914","author":"Byun","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.arcmed.2023.102899_bib0085","doi-asserted-by":"crossref","first-page":"14999","DOI":"10.18632\/aging.203061","article-title":"Inhibiting USP8 overcomes hepatocellular carcinoma resistance via suppressing receptor tyrosine kinases","volume":"1311","author":"Zhu","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.arcmed.2023.102899_bib0086","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s13046-019-1262-4","article-title":"USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer","volume":"381","author":"Man","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.arcmed.2023.102899_bib0087","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1371\/journal.pmed.0020073","article-title":"Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain","volume":"23","author":"Pao","year":"2005","journal-title":"PLoS Med"},{"key":"10.1016\/j.arcmed.2023.102899_bib0088","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00204-014-1275-x","article-title":"EGFR mediates docetaxel resistance in human castration-resistant prostate cancer through the Akt-dependent expression of ABCB1 (MDR1)","volume":"894","author":"Hour","year":"2015","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.arcmed.2023.102899_bib0089","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1517\/14740338.5.3.469","article-title":"Gefitinib: an adverse effects profile","volume":"53","author":"Cersosimo","year":"2006","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.arcmed.2023.102899_bib0090","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/jnci\/djp458","article-title":"E2F1 in melanoma progression and metastasis","volume":"1022","author":"Alla","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.arcmed.2023.102899_bib0091","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1530\/ERC-16-0206","article-title":"E2F1-mediated human POMC expression in ectopic Cushing's syndrome","volume":"2311","author":"Araki","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.arcmed.2023.102899_bib0092","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1210\/js.2016-1053","article-title":"EGFR Induces E2F1-mediated corticotroph tumorigenesis","volume":"12","author":"Araki","year":"2017","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.arcmed.2023.102899_bib0093","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1507\/endocrj.EJ18-0491","article-title":"Lapatinib decreases the ACTH production and proliferation of corticotroph tumor cells","volume":"666","author":"Asari","year":"2019","journal-title":"Endocr J"},{"key":"10.1016\/j.arcmed.2023.102899_bib0094","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1172\/JCI60417","article-title":"EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas","volume":"12112","author":"Fukuoka","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.arcmed.2023.102899_bib0095","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/cmdc.200900409","article-title":"Synthesis and biological evaluation of 9-oxo-9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile analogues as potential inhibitors of deubiquitinating enzymes","volume":"54","author":"Colombo","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.arcmed.2023.102899_bib0096","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1021\/ml200276j","article-title":"Selective dual inhibitors of the cancer-related deubiquitylating proteases USP7 and USP47","volume":"310","author":"Weinstock","year":"2012","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.arcmed.2023.102899_bib0097","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1507\/endocrj.EJ19-0239","article-title":"Ubiquitin-specific protease 8 inhibitor suppresses adrenocorticotropic hormone production and corticotroph tumor cell proliferation","volume":"672","author":"Kageyama","year":"2020","journal-title":"Endocr J"},{"key":"10.1016\/j.arcmed.2023.102899_bib0098","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.4103\/0366-6999.189047","article-title":"Inhibition of ubiquitin-specific peptidase 8 suppresses adrenocorticotropic hormone production and tumorous corticotroph cell growth in AtT20 cells","volume":"12917","author":"Jian","year":"2016","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.arcmed.2023.102899_bib0099","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"3596382","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.arcmed.2023.102899_bib0100","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1038\/s41467-022-29401-6","article-title":"USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy","volume":"131","author":"Xiong","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.arcmed.2023.102899_bib0101","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41418-022-01102-z","article-title":"Targeting ubiquitin-specific protease 8 sensitizes anti-programmed death-ligand 1 immunotherapy of pancreatic cancer","volume":"302","author":"Yang","year":"2023","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.arcmed.2023.102899_bib0102","doi-asserted-by":"crossref","first-page":"e23888","DOI":"10.1371\/journal.pone.0023888","article-title":"Stressing the ubiquitin-proteasome system without 20S proteolytic inhibition selectively kills cervical cancer cells","volume":"68","author":"Anchoori","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.arcmed.2023.102899_bib0103","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.4161\/cc.20174","article-title":"Chalcone-based small-molecule inhibitors attenuate malignant phenotype via targeting deubiquitinating enzymes","volume":"119","author":"Issaenko","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.arcmed.2023.102899_bib0104","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1089\/ars.2013.5322","article-title":"Induction of tumor cell apoptosis by a proteasome deubiquitinase inhibitor is associated with oxidative stress","volume":"2117","author":"Brnjic","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.arcmed.2023.102899_bib0105","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1158\/1078-0432.CCR-13-2658","article-title":"Small-molecule RA-9 inhibits proteasome-associated DUBs and ovarian cancer in vitro and in vivo via exacerbating unfolded protein responses","volume":"2012","author":"Coughlin","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.arcmed.2023.102899_bib0106","first-page":"80","article-title":"Effects of selected deubiquitinating enzyme inhibitors on the proliferation and motility of lung cancer and mesothelioma cell lines","volume":"571","author":"Mirzapoiazova","year":"2020","journal-title":"Int J Oncol"},{"key":"10.1016\/j.arcmed.2023.102899_bib0107","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1530\/ERC-21-0093","article-title":"USP8 inhibitor RA-9 reduces ACTH release and cell growth in tumor corticotrophs","volume":"288","author":"Treppiedi","year":"2021","journal-title":"Endocr Relat Cancer"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440923001376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440923001376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T09:14:43Z","timestamp":1741166083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440923001376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":107,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0188440923001376"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2023.102899","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Spectrum of USP8 Pathogenic Variants in Cushing's Disease","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2023.102899","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102899"}}